Immediate Impact

1 by Nobel laureates 2 from Science/Nature 55 hit
Sub-graph 1 of 23

Citing Papers

Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)
2025 Hit
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Hit
3 intermediate papers

Works of Liheng Ma being referenced

Assessment of the expression of the immune checkpoint molecules PD‐1, CTLA4, TIM‐3 and LAG‐3 across different cancers in relation to treatment response, tumor‐infiltrating immune cells and survival
2019
Prevalence of ROS1 fusion in Chinese patients with non‐small cell lung cancer
2018

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Liheng Ma 249 218 195 183 106 33 589
Xiangyu Wang 229 0.9× 176 0.8× 126 0.6× 271 1.5× 109 1.0× 41 677
Christophe Hermans 253 1.0× 118 0.5× 117 0.6× 227 1.2× 138 1.3× 32 640
Dongxu Qiu 187 0.8× 107 0.5× 215 1.1× 134 0.7× 105 1.0× 38 536
G. Hu 271 1.1× 181 0.8× 111 0.6× 327 1.8× 61 0.6× 33 661
Jean‐Baptiste Oudart 239 1.0× 169 0.8× 121 0.6× 193 1.1× 72 0.7× 32 569
Kuan‐Li Wu 297 1.2× 245 1.1× 212 1.1× 201 1.1× 64 0.6× 36 593
Pranita Atri 372 1.5× 176 0.8× 82 0.4× 343 1.9× 140 1.3× 33 662
Adam R. Wolfe 260 1.0× 238 1.1× 150 0.8× 308 1.7× 122 1.2× 33 630
Yinxing Zhu 199 0.8× 124 0.6× 157 0.8× 234 1.3× 89 0.8× 31 527
Qingyang Gu 349 1.4× 149 0.7× 112 0.6× 231 1.3× 60 0.6× 26 657

All Works

Loading papers...

Rankless by CCL
2026